$24.25
+1.82 (+8.11%)
GEN News5 articles
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.
Siemens Gains on Major Copenhagen Rail Contract Ahead of Key Earnings Week
Siemens shares advanced 2.45% following a €3 billion automated train contract win in Copenhagen. Investors now focus on upcoming Q1 results and a proposed €5.35 dividend.
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.
Siemens Gains on €3 Billion Copenhagen Automated Train Contract Ahead of Quarterly Results
Siemens shares rose 2.45% to €250.50 after its Mobility unit, with partner Stadler, secured a €3 billion framework contract for 226 driverless trains in Copenhagen. The company reports Q1 earnings and holds its AGM on February 12.
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.